Women, Diversity, and Sexual Minorities in the Psychedelic Community
Hosted by The Chacruna Institute for Psychedelic Plant Medicines
Although the enormous growth of interest in and research on psychedelic substances’ potential for psychological healing and consciousness expansion is exciting, there are shadow sides of the psychedelic community that require attention. Women’s contributions to the field have too often been downplayed, and the abuse of women in some psychedelic underground circles has been a serious problem. Also, people of color, LGBTQ and other minority communities have been under-represented in psychedelic conclaves. A stellar panel of figures at the cutting-edge of inclusivity advocacy in the psychedelic community will share their perspectives on how to remedy these problems. Hosted by Bia Labate, Ph.D., Executive Director of the Chacruna Institute, on the faculty of The California Institute of Integral Studies (CIIS), and Public Education and Culture Specialist at the Multidisciplinary Association for Psychedelic Studies (MAPS). With: Emily Sinclair, leader of the Ayahuasca Community Guide for the Awareness of Sexual Abuse initiative; Sarah Scheld, a coordinator of MAPS’ MDMA Therapy Training Program; Monnica T. Williams, Ph.D., Associate Professor of psychology at the University of Connecticut; Sara Reed, MS, MFT, a study therapist in the Psilocybin-assisted Psychotherapy for Major Depression initiative at Yale University.
Larkspur Room
October 19th | 4:30 pm to 6:00 pm
Panelists
Bia Labate
Executive Director
Chacruna Institute for Psychedelic Plant Medicines
Beatriz Caiuby Labate, Ph.D. (in social anthropology from the State University of Campinas (UNICAMP), Brazil, is Executive Director of the Chacruna Institute for Psychedelic Plant Medicines. She is also Adjunct Faculty at the East-West Psychology Program at the California Institute of Integral Studies (CIIS) and Public Education and Culture Specialist at the Multidisciplinary Association for Psychedelic Studies (MAPS). She has published twenty books.Emily Sinclair
Anthropologist
Chacruna Institute for Psychedelic Medicines
Emily Sinclair is an anthropologist whose research focuses on the globalization of ayahuasca and its impacts, especially in the Iquitos region of Peru where she was based between 2014 and 2018. She is a member of the Ayahuasca Community Committee of the Chacruna Institute for Psychedelic Medicines, and a leader of the Ayahuasca Community Guide for the Awareness of Sexual Abuse initiative.Sarah Scheld
Training and Supervision Associate
Multidisciplinary Association for Psychedelic Studies
Sarah Scheld, a Training and Supervision Associate for the Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation, helps coordinate and develop curriculum for their MDMA Therapy Training Program. She recently collaborated on a Code of Ethics for MDMA-assisted psychotherapy providers. Her work focuses on trauma awareness, somatics, and the ethical use of psychedelic medicines to help heal people, communities, culture and the environment.Monnica Williams
Chair of the Board
Chacruna Institute for Psychedelic Plant Medicines
Monnica T. Williams, Ph.D., is a board-certified licensed clinical psychologist, an Associate Professor in the University of Connecticut's Department of Psychological Sciences, and Clinical Director of the Behavioral Wellness Clinic in Tolland, Connecticut. Her work is focused on improving cultural competence in the delivery of mental health care services and reducing barriers to care. She sits on the Advisory Board of the Chacruna Institute.Sara Reed
Marriage and Family Therapist
Behavioral Wellness Clinic
Sara Reed, MS, MFT, is a Marriage and Family Therapist at the Behavioral Wellness Clinic in Tolland, Connecticut and a Study Therapist for the Psilocybin-assisted Psychotherapy for Major Depression initiative at Yale University. A member of the Multidisciplinary Association for Psychedelic Studies (MAPS) Advisory Board, Sara also served as a Sub-Investigator and Study Coordinator for MAPS' Phase 2 MDMA Clinical Study of Posttraumatic Stress Disorder (PTSD).
Let Bioneers be your hub for information and action regarding the world’s most pressing social and environmental challenges: Subscribe to the weekly Bioneers Pulse email newsletter.